Categories AlphaGraphs, Earnings, Finance

Charles Schwab (SCHW) Q4 revenue up 13%; earnings miss estimates

Financial services company The Charles Schwab Corporation (NYSE: SCHW) on Tuesday reported higher earnings and revenues for the fourth quarter of 2021. However, the numbers missed Wall Street’s forecast, and the company’s stock dropped in the premarket session soon after the announcement.

The Charles Schwab Corporation Q4 2021 earnings infographic

Total revenues increased 13% year-over-year to $4.71 billion in the final three months of fiscal 2021. However, the number missed Wall Street’s estimates.

Net profit, on an adjusted basis, rose to $0.86 per share during the quarter from $0.74 per share in the same period of last year but came in below the consensus forecast. Unadjusted net income was $1.58 billion or $0.76 per share, compared to $1.14 billion or $0.57 per share last year.

Charles Schwab’s stock has gained about 35% in the past six months and reached a record high this month. It dropped sharply Tuesday morning following the earnings release, after closing the last session higher.

Prior Performance

  • The Charles Schwab Corporation Q3 2021 earnings infographic
  • Charles schwab earnings
  • Charles Schwab reports Q3 2020 earnings results

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top